Millions of people suffer from debilitating and potentially deadly health conditions, with limited (if any) treatment options available to them. The Accelerated Approval Pathway (AAP) offers patients access to promising, yet unproven, treatments in a timely manner. The question remains: Is it fulfilling its potential?
Read the story of how Commonwealth Medicine experts applied over two decades of experience to create Massachusetts’ award winning state supplement program and learn more about what our team can do to enhance yours.
With the COVID-19 Delta variant on the rise and the number of newly vaccinated remaining flat, health care organizations are dusting off their infection prevention plans to face the latest threat. In her second blog using the pandemic experience of a skilled nursing facility client, Christine Dixon, RN, MSN, MMHC, shares how Commonwealth Medicine can help organizations refine their infection control and prevention practices and, in some cases, adopt new ones.
Still reeling from the impact of COVID-19 on the health of their patients as well as their operational plans, health care organizations of all types know that preparing now for the next crisis is critical. Using the pandemic experience of a skilled nursing facility client, Christine Dixon, RN, MSN, MMHC, shares how Commonwealth Medicine can help organizations reap the benefits of proven methods of operations planning to successfully handle unexpected events in a new blog.
Commonwealth Medicine’s Enhanced Coordination of Benefits program takes a comprehensive and collaborative approach to controlling costs. Our ECOB Program Manager, Matthew Hemberger, blogs on how our experts use a combination of high tech data review and high touch engagement with providers and families to improve the coordination of care and save Masshealth millions.
Accountable care organizations are turning to community based organizations more and more often to help achieve their cost and health care outcome goals. But CBOs can have a difficult time positioning themselves as attractive prospects for partnership. Catie Geary, MPH, shares how Commonwealth Medicine can help CBOs communicate the high-value benefits they can bring to potential ACO partners in a new blog.
We are proud to support the HHS Office of Minority Health and other partners to encourage communities to be vaccine-ready. This National Minority Health Month, learn what role we all play in raising vaccine confidence.
The next wave of patient care is here. Digital therapeutics (DTx) – such as virtual reality technologies, mobile applications, even AI-powered assistants – offer patients different options for therapeutic interventions and increase access along the way. Pharmacy expert Soumya Vishwanath, PharmD, evaluates how DTx is reshaping the digital health landscape and its potential impact on key stakeholders, including patients, providers, and health insurance companies.
Novel antidepressants offering relief from postpartum depression and treatment-resistant depression, as well as combinations of existing drugs, are beginning to reach FDA approval. ComMed pharmacy expert Ashley Chiara discusses exciting developments in the antidepressant pipeline in a new blog.
In this blog, Senior Director for Process Improvement Nick Comeau discusses how organizations can become more productive by developing practices and policies that empower staff and create a culture where employees are valued for their insights and contributions.
